Stocks / Pharmaceuticals
ERASPharmaceuticals
Erasca, Inc.
$16.021d +2.0%5d -0.7%settled close · 2026-09-10
Mkt cap $4.6B (9/8)β 1.4152w $1.43–23Shares 310.8MInd. Pharmaceutical PreparationsNasdaq since 2021Emp. 103HQ San Diego, CAerasca.com
Who’s talkingIdea Scout · free
Who’s talking about ERAS
No tracked investor commentary on ERAS yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 10 Nov 2026 after the close
Confirmed date · consensus EPS -0.13. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 11 Aug 2026 | after the close | -0.14 vs -0.10 | +3.2% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ERAS’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 13 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-10 | ||||||
| 2026-08-11 | ||||||
| 2026-06-30 | ||||||
| 2026-06-29 | ||||||
| 2026-06-26 | ||||||
| 2026-06-22 | ||||||
| 2026-04-29 | ||||||
| 2026-04-28 | ||||||
| 2026-04-16 | ||||||
| 2026-04-15 | ||||||
| 2026-04-14 | ||||||
| 2026-04-13 | ||||||
| 2026-04-01 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ERAS is in this morning’s Brief.
Get The Brief — $20/mo →